Abstract : Acute internal carotid artery (ICA) occlusion may result in severe disability or death. Revascularization by carotid artery stenting after treatment with intravenous (iv) recombinant tissue-type plasminogen activator (rt-PA) has been documented. However, there are few reports on emergency carotid endarterectomy (CEA) within 24 hours after the iv administration of rt-PA. We treated a 58-year-old man with right ICA occlusion with iv rt-PA. Although partial recanalization of the ICA was obtained, severe stenosis at the origin of the ICA persisted and he developed fluctuating neurological deficits. To prevent progressive stroke he underwent CEA 10.5 hours after rt-PA treatment. Thereafter his blood pressure was strictly controlled under sedation. During and after CEA there were no hemorrhagic complications. Our findings suggest that emergency CEA may be an option to address symptomatic severe residual ICA stenosis even after iv rt-PA therapy delivered in the acute stage.
INTRODUCTION
The morbidity and mortality rates after acute ischemic stroke from internal carotid artery (ICA) occlusion are high (1, 2) . Only 18 -26% of patients with acute ICA occlusion who received intravenous (iv) recombinant tissue -type plasminogen activator (rt-PA) therapy alone showed early recanalization (3 -6) .
The addition of endovascular -to iv rt-PA therapy was suggested to be effective in patients with acute ICA occlusion (7 -9) . However, when carotid artery stenting (CAS) is the salvage method in patients with cervical ICA stenosis who had undergone iv rt-PA treatment, antithrombotic-including antiplatelet agents are required during and after CAS to prevent stent thrombosis. The administration of such agents within 24 hours after rt-PA may increase the risk for major bleeding, in particular of intracerebral hemorrhage.
There are few reports of emergent carotid endarterectomy (CEA) within 24 hours after rt-PA treatment in patients with acute ICA occlusion. We report a patient who underwent emergent CEA after iv rt-PA treatment and whose outcome was good.
CASE REPORT
A 58-year-old man was referred to our emergency room 90 minutes after the sudden onset of left hemiplegia and dysarthria during the consumption of alcohol. His lifestyle included smoking and drinking and he had a history of hypertension, diabetes mellitus, and dyslipidemia. At the time of his admission he was confused (Glasgow Coma Scale ; E4V4M6) ; neurological findings were consciousness disturbance, conjugate deviation to the right, dysarthria, left facial palsy, and left severe hemiparesis (manual muscle testing : upper 1/5 lower 3/5). His initial National Institute of Health Stroke Scale (NIHSS) score was 14. Neither an abnormal cardiac rhythm nor congestiveheart failure was noted. Diffusion-weighted imaging (DWI) showed multiple high-intensity lesions in the right frontal lobe and insular cortex ( Figure 1A ). Magnetic resonance angiography (MRA) revealed occlusion of the cervical portion of the right ICA, there was faint flow in the right middle -and anterior cerebral arteries via the anterior-and posterior communicating artery providing collateral circulation ( Figure 1B ). Echo lucency was low on ultrasound images of a carotid atherosclerotic plaque. He was treated with iv rt-PA (0.6 mg/kg) 3 hours post-onset.
MRA images obtained immediately after the iv administration of rt-PA demonstrated no recanalization of the right ICA. On DWI scans an ischemic region was clearly visualized ; the area had not expanded ( Figure 2 ). The conjugate deviation to the right disappeared, his level of consciousness improved, and his NIHSS score was 9. As it was unclear whether MRA indicated complete-or pseudo-occlusion of the ICA we performed cerebral angiography to determine his hemodynamic status. Based on North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria it showed 95% stenosis of the proximal ICA ; the blood flow was anterograde and slow ( Figure 3 ) without supplementary flow from other arteries. He subsequently developed unstable neurological deficits and his NIHSS score fluctuated between 7 and 11. To prevent stroke progression we decided to perform CEA 10.5 hours after the administration of iv rt-PA. Coronary angiography did not identify coronary artery disease and we considered him able to tolerate general anesthesia.
Under general anesthesia he underwent CEA with intraoperative shunting because the blood flow was anterograde and faint. The procedure was uneventful and there were no bleeding complications. The atherosclerotic soft plaque harboring cholesterol was fragile and led to thrombus formation.
He was kept under continuous sedation with dexmedetomidine for 4 days after CEA to avoid intracerebral hemorrhage related to hyperperfusion syndrome and his blood pressure was strictly controlled. In addition, we administered the free radical scavenger edaravone for two weeks. Postoperatively his left severe hemiparesis improved slowly ; his NIHSS score was 5. MRA performed one day post-CEA revealed that his ICA was free of stenosis ; DWI revealed no new ischemic lesions (Figure 4 ). Computed tomography performed 3 and 10 days post-CEA showed no intracerebral hemorrhage. One month post-CEA he could walk with a stick and was discharged. His modified Rankin scale (mRS) score 3 months after CEA was 3. 
DISCUSSION
We reported a patient with acute ICA occlusion who underwent CEA 10.5 hours after the administration of iv rt-PA. We paid careful attention to stop intraoperative bleeding, we controlled his postoperative blood pressure under sedation, and administered edaravone to prevent hyperperfusion. There were no hemorrhagic complications.
In patients with acute ICA occlusion it is difficult to obtain recanalization after the administration of iv rt-PA alone (3) (4) (5) (6) . Even after recanalization severe extracranial ICA stenosis may persist, increasing the risk for progressive stroke or ICA reocclusion in the acute phase. Salvage methods for severe residual stenosis at the origin of the ICA include CAS and CEA.
CAS can be performed non-invasively and immediately after evaluation of the cerebral hemodynamic status on cerebral angiographs. It may help to address a critical stenosis resulting in a reduction in the cerebral blood flow in the affected hemisphere during the intervention. Some patients who underwent emergent CAS after rt-PA have been reported (10 -12) ; however, this procedure requires the administration of anticoagulants during and after the operation and may elicit hemorrhagic complications. According to Kimura et al. (13) , recanalization between 1 and 24 hours after rt-PA therapy was a strong predictor of intracerebral hemorrhage. Consequently, they argued against the administration of antithrombotic agents. Villwock et al. (14) reported that CAS plus the administration of rt-PA increased the odds for complications and death. In addition, in the presence of vulnerable carotid plaques or tortuous carotid lesions, and when it is difficult to access the ICA, CAS may not be appropriate.
On the other hand, some patients underwent early CEA after thrombolysis (12, 15 -17) . Yong et al. (15) who assessed the safety of CEA performed 0 -54 days after thrombolysis for acute ischemic stroke found that the incidence of intracerebral hemorrhage within the first 30 days was 3%. They suggested that CEA after thrombolysis would be safe.
Patients who undergo emergency CEA within 24 hours after rt-PA are at high risk for intracerebral hemorrhage and only 3 such patients have been reported (18 -20) . They underwent the procedure 4.2 -, 2 -, and 6 hours after the iv administration of rt-PA for ICA pseudo-occlusion or occlusion of the common carotid artery and the ICA. Their NIHSS score before CEA was 22, 19, and 5 and none suffered peri-operative hemorrhagic complications. These reports indicate that careful patient selection and post-CEA management are extremely important. Patients with mild neurological deficits, without significant ischemic areas, and those with good collateral flow may be candidates for emergency CEA after rt-PA. Although our patient manifested unstable neurological deficits, angiographs acquired immediately after the administration of iv rt-PA showed good collateral flow that may have contributed to his good outcome.
To avoid post-CEA intracerebral hemorrhage, we administered edaravone and paid special attention to avoid postoperative hypertension. According to Yagi et al. (21) , while rt-PA induced the upregulation of matrix metalloproteinase-9 (MMP-9) and elicited intracerebral hemorrhage in rats subjected to 3 -hour middle cerebral artery occlusion, edaravone inhibited rt-PA-induced cerebral hemorrhage by inhibiting the expression of MMP-9. In our patient, edaravone plus strict blood pressure control under sedation appears to have prevented post-CEA intracerebral hemorrhage.
Pharmacokinetically, iv rt-PA is very short acting ; its serum half-life is only about 5 minutes and Cmax is reached 55 minutes after the start of its administration. At 90 minutes the blood level decreases to 10% of Cmax, and at 4 hours it is 1% of Cmax (18, 20) . We posit that at 10.5 hours the effects of iv rt-PA had worn off sufficiently to render CEA safe in our patient. However, plasma markers to confirm this hypothesis have not been established yet and, further study is needed.
To prevent perioperative complications, in most cases CEA should not be performed less than 24 hours after thrombolysis. However, when the patient is neurologically unstable and the institution has enough experience with CEA, it may be considered as an optional treatment. In our patient, emergency CEA for residual severe ICA stenosis after iv rt-PA treatment resulted in the improvement of his neurological signs and there were no complications. As this report presents our experience with a single patient, further investigations are needed to determine the safety and efficacy of emergency CEA after iv rt-PA treatment and to identify patients who are candidates for emergency CEA.
CONCLUSION
We reported a patient with acute ICA occlusion who underwent successful CEA 10.5 hours after the administration of iv rt-PA. Emergency CEA may be an option to address post-treatment severe residual ICA stenosis. Additional studies are needed to confirm the safety and efficacy of emergency CEA.
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